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Abstract
Background: Malignant pleural mesothelioma (MPM) is an aggressive malignant neoplasm that
was thought to be a localised disease with limited metastatic capability. However, recent post-
mortem studies have identified metastases to the central nervous system (CNS) in about 3% of
cases.
Case Description: We present the case of a 65-year-old with a solitary supratentorial metastatic
deposit of MPM treated with surgical resection and adjuvant whole brain radiotherapy. Despite a
good surgical outcome with symptomatic recovery, the patient died of cardiopulmonary
compromise five months postoperatively.
Conclusions: Although rare, CNS metastasis of MPM is a condition that neurosurgeons should be
aware of. CNS metastases may occur via three distinct mechanisms, namely perineural spread,
leptomeningeal carcinomatosis and, most commonly, haematogenous spread leading to
parenchymal deposits. Surgical resection of these deposits can lead to symptomatic
improvement, and together with radiotherapy, to local disease control. However, the overall
survival remains poor.
Categories: Neurosurgery, Oncology
Keywords: mesothelioma, brain metastasis, spine metastasis, metastasis, neurosurgery, neuro-oncology,
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Introduction
Malignant mesothelioma is an aggressive malignant neoplasm that can arise from mesothelial
cells of the pleura, peritoneum, pericardium, and tunica vaginalis of the testis. The main cause of
malignant pleural mesothelioma (MPM) is asbestos exposure, which can occur as an
occupational hazard, for example, in ship builders and construction workers. Presentation
usually trails exposure by 20-30 years [1].
For many years, MPM was thought to be a localised disease with limited metastatic capability,
but a large post-mortem study of 318 MPM patients has identified that spread to the
contralateral thoracic cavity and distant sites can be seen in a majority [2]. Metastases to the
central nervous system (CNS), however, are rare, occurring in about 3% of post-mortem cases [2-
3].
We present the case of a solitary supratentorial metastatic deposit and discuss the treatment
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strategy. We also conducted a literature review by searching the MEDLINE database for
“malignant mesothelioma AND (central nervous system OR brain OR spinal cord)". We examined
the three purported mechanisms of spread of MPM to the CNS and potential treatment options
for each, specifically looking at the treatment strategies and overall survival of patients with
hemispheric metastases.
Informed consent from the patient’s next of kin was sought and obtained.
Case Presentation
A 65-year-old left-handed gentleman presented to the emergency department with a focal
seizure involving the left upper limb. His only past medical history of note was a left malignant
pleural mesothelioma for which he had completed six cycles of pemetrexed and cisplatin
chemotherapy one year previously. It had shown excellent partial radiological response and was
now under surveillance with stable appearances on follow-up computed tomography (CT) scans.
Neurological examination revealed isolated left upper limb weakness (4/5 on MRC scale) and an
unsteady gait. CT and magnetic resonance (MR) imaging revealed a heterogeneously enhancing
intrinsic lesion centred around the right pre-central gyrus measuring 22 mm x 30 mm x 20 mm
with extensive surrounding oedema (Figure 1), highly suspicious of a solitary metastasis. Staging
CT revealed stable lung disease in the thorax and no evidence of any new primary cancer. The
patient was commenced on high dose dexamethasone and phenytoin, and surgical resection was
planned. Preoperative neurological examination showed progression of his left hemiparesis to
hemiplegia. He underwent gross total resection, confirmed on postoperative MR imaging (Figure
2). Light microscopy and immunohistochemistry of the excised lesion confirmed the suspected
diagnosis of metastatic mesothelioma (Figure 3).
FIGURE 1: MR images showing solitary intrinsic lesion centred around the pre-central gyrus,
confirmed to be metastatic deposit of MPM on histological assessment.
A/B: Post-gadolinium T1-weighted images; C: T2-weighted image
FIGURE 2: Postoperative MR images confirming gross total resection.
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A/B: Post-gadolinium T1-weighted images showing some hyperintense material in the cavity that
does not enhance compared to pre-contrast sequence; C: T2-weighted image
FIGURE 3: Histological images confirming diagnosis of MPM.
A: light microscopy with haematoxylin & eosin stain showing a malignant neoplasm featuring
sheets of cohesive epithelioid and plump spindle cells with large nuclei, lobulated nuclear
outlines and prominent nucleoli. There were multiple foci of tumour necrosis and conspicuous
mitotic activity. No glandular or squamous differentiation was identified. B/C:
Immunohistochemical preparations showing diffuse and strong positivity for broad-spectrum
cytokeratin AE1/3 (B) and patchy but strong staining for calretinin (C). There was also patchy but
strong staining for cytokeratin 5/6 and epithelial membrane antigen with only weak focal staining
for D2-40.
After an uncomplicated recovery, he was discharged on postoperative day three. At follow-up on
postoperative day 10, he was able to mobilise without a frame and went on to receive 20 Gy of
whole brain radiotherapy in five fractions. Despite this, he died of cardiopulmonary compromise
from his mesothelioma five months later.
Informed consent from the patient’s next of kin (wife) was sought and obtained for the
publication of this case report. 
Discussion
We describe the case of a solitary metastatic deposit of MPM with overall survival of five months
following successful surgical resection and adjuvant whole brain radiotherapy. Given the
increasing incidence of the disease and the recognition that up to 3% of patients may have CNS
metastasis, it is important to consider the different mechanisms of metastasis of MPM to the
CNS and potential treatment strategies for each.
Three distinct mechanisms for metastatic spread to the CNS have been described in the
literature. The first is via perineural spread resulting in nerve root and spinal cord compression
[4-9]. Whilst one study reported successful gross total resection of an intradural extramedullary
lesion [8], other authors reported intramedullary tumour with subtotal resection [4, 6-7, 10]. In
general, authors report some functional recovery and recommend surgical decompression for
such cases, although in one case, stereotactic radiosurgery was used to palliate symptoms
[10]. Median overall survival after diagnosis of spinal cord compression is reported at 75-360
days [11].
The second mechanism is haematogenous spread leading to diffuse leptomeningeal
carcinomatosis [12-13]. The diagnosis is made by contrast-enhanced magnetic resonance
imaging and cytology from cerebrospinal fluid. Neither of the two cases reported in the
literature discuss successful treatment strategies [12-13].
2015 Chari et al. Cureus 7(1): e241. DOI 10.7759/cureus.241 3 of 5
Paper Age Sex Number of Deposits Treatment Strategy Survival Notes
Kitai, et al.
1995 62 M Single
Gross total resection + whole brain
radiotherapy
36
months*  
Wronski, et
al. 1993 52 F Single Gross total resection 10 days
Cause of death:
Constrictive
pericardial disease
Hurmuz, et
al. 2009 56 F Multiple Whole brain radiotherapy 1 month
Cause of death:
Respiratory failure
Colleoni, et
al. 1996 55 M Multiple
Chemotherapy with lomustine, carboplatin,
vinorelbine, fluorouracil and folates Unknown  
Krishnaraj,
et al. 2003 64 M Single Gross total resection + radiotherapy Unknown
Palliative
radiotherapy
Mah, et al.
2004 67 M Two Gross total resection
3
months*  
Ishikawa, et
al. 2010 56 M Single
Gross total resection + whole brain
radiotherapy
7
months*
Recurrence after 7
months, repeat
surgery performed
Winfree, et
al. 2004 71 F Single
Gross total resection + whole brain
radiotherapy + chemotherapy with
adriamycin and cisplatin
8 months
Cause of death:
Cardiopulmonary
arrest
Hortobagyi,
et al. 2008 71 M Multiple Debulking largest mass Unknown  
This case 65 M Single Gross total resection + whole brainradiotherapy 5 months
Cause of death:
Respiratory failure
The third, and most common, mechanism is haematogenous spread leading to solitary
metastases to the supra- and infra-tentorial compartments [11]. Solitary CNS metastases were
first reported in 1983 [14]. In 1991, a large post-mortem study found CNS metastases in 3% of
171 mesotheliomas [3], findings that have been recently corroborated [2].
The first report of successful neurosurgical intervention for solitary CNS metastasis of MPM was
in 1995, where gross total resection of a solitary right frontal lesion followed by whole brain and
local radiotherapy was found to improve neurological symptoms and result in a 36-month
recurrence-free survival [15]. Since then, a number of studies have reported intervention for
cerebral metastases of MPM (Table 1) [15-19]. Treatment strategies have been highly
heterogeneous, and overall survival has been poor despite aggressive management (Table 1).
However, the published cases, including the current case, suggest that the cause of death usually
surrounds progression of thoracic disease with low surgical morbidity and effective symptom
control from neurosurgical intervention. This supports the case for treating cerebral metastases.
A recent review puts median overall survival for solid brain metastases at 83-183 days [11], which
concurs with the cases identified in the literature, as seen in Table 1.
TABLE 1: Case reports of active management of cerebral metastases of malignant pleural mesothelioma.
Case reports of active management of cerebral metastases of malignant pleural mesothelioma [15-23]
* Indicates alive at the time of reporting.
Conclusions
CNS metastasis of MPM is rare but a condition that neurosurgeons should be aware of. Surgical
resection of symptomatic solitary metastases can lead to symptomatic improvement, and
together with radiotherapy, to local disease control. However, the overall survival remains poor. 
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